ArticleMolecular therapy. Methods & clinical development2023

Persistence of exon 2 skipping and dystrophin expression at 18 months after U7snRNA-mediated therapy in the Dup2 mouse model.

Liubov V Gushchina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.